Retrieve available abstracts of 10 articles: HTML format
Single Articles
April 2025
DAILY JP, Parikh S Malaria.
N Engl J Med. 2025;392:1320-1333. PubMed
November 2024
LAMERS OAC, Franke-Fayard BMD, Koopman JPR, Roozen GVT, et al Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria
Parasite.
N Engl J Med. 2024;391:1913-1923. PubMedAbstract available
May 2024
FRANCES I, Muruzabal MJ Red-Cell Rosette Formation in Malaria.
N Engl J Med. 2024;390:1905. PubMed
April 2024
MUNDEL T The Quest for Transformative Tools to Eradicate Malaria.
N Engl J Med. 2024 Apr 26. doi: 10.1056/NEJMe2402430. PubMed
KAYENTAO K, Ongoiba A, Preston AC, Healy SA, et al Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
N Engl J Med. 2024 Apr 26. doi: 10.1056/NEJMoa2312775. PubMedAbstract available
December 2023
MENARD D, Mihreteab S, Fidock DA Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. Reply.
N Engl J Med. 2023;389:2497-2498. PubMed
BAYIH AG, Feleke SM, Pillai DR Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.
N Engl J Med. 2023;389:2497. PubMed
September 2023
MIHRETEAB S, Platon L, Berhane A, Stokes BH, et al Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.
N Engl J Med. 2023;389:1191-1202. PubMedAbstract available
GREENWOOD B Artemisinin-Resistant and HRP-Negative Malaria Parasites in Africa.
N Engl J Med. 2023;389:1162-1164. PubMed
August 2023
CONRAD MD, Asua V, Garg S, Giesbrecht D, et al Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.
N Engl J Med. 2023;389:722-732. PubMedAbstract available